Veronica Viedma-Moreno

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Absence of EGFR signalling in granulocytic cells relieves immunosuppression sensitising CRC metastases to immune checkpoint therapy.

Absence of EGFR signalling in granulocytic cells relieves immunosuppression sensitising CRC metastases to immune checkpoint therapy.

Journal: Cell death and differentiation

Published: April 09, 2025

TYK2 Promotes Immunosurveillance of Colorectal Cancer Liver Metastasis.

TYK2 Promotes Immunosurveillance of Colorectal Cancer Liver Metastasis.

Journal: Cancer research

Published: November 07, 2024

EGFR controls transcriptional and metabolic rewiring in KRASG12D colorectal cancer.

EGFR controls transcriptional and metabolic rewiring in KRASG12D colorectal cancer.

Journal: EMBO molecular medicine

Published: May 16, 2024

Inducible overexpression of a FAM3C/ILEI transgene has pleiotropic effects with shortened life span, liver fibrosis and anemia in mice.

Inducible overexpression of a FAM3C/ILEI transgene has pleiotropic effects with shortened life span, liver fibrosis and anemia in mice.

Journal: PloS one

Published: January 10, 2023

AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer.

AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 22, 2020

Serum Myostatin is Upregulated in Obesity and Correlates with Insulin Resistance in Humans.

Serum Myostatin is Upregulated in Obesity and Correlates with Insulin Resistance in Humans.

Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association

Published: August 04, 2018

EPHA2 Is a Predictive Biomarker of Resistance and a Potential Therapeutic Target for Improving Antiepidermal Growth Factor Receptor Therapy in Colorectal Cancer.

EPHA2 Is a Predictive Biomarker of Resistance and a Potential Therapeutic Target for Improving Antiepidermal Growth Factor Receptor Therapy in Colorectal Cancer.

Journal: Molecular cancer therapeutics

Published: June 14, 2018

Osteopontin-deficient progenitor cells display enhanced differentiation to adipocytes.

Osteopontin-deficient progenitor cells display enhanced differentiation to adipocytes.

Journal: Obesity research & clinical practice

Published: October 19, 2017

AQP3 is regulated by PPARγ and JNK in hepatic stellate cells carrying PNPLA3 I148M.

AQP3 is regulated by PPARγ and JNK in hepatic stellate cells carrying PNPLA3 I148M.

Journal: Scientific reports

Published: July 19, 2017

Adiponectin regulates AQP3 via PPARα in human hepatic stellate cells.

Adiponectin regulates AQP3 via PPARα in human hepatic stellate cells.

Journal: Biochemical and biophysical research communications

Published: May 24, 2017

Peptide-based vaccination against OPN integrin binding sites does not improve cardio-metabolic disease in mice.

Peptide-based vaccination against OPN integrin binding sites does not improve cardio-metabolic disease in mice.

Journal: Immunology letters

Published: August 22, 2016

Osteopontin is a key player for local adipose tissue macrophage proliferation in obesity.

Osteopontin is a key player for local adipose tissue macrophage proliferation in obesity.

Journal: Molecular metabolism

Published: August 16, 2016

Showing 1-12 of 17

Last Updated: 09/26/2026